Skip to main content
Premium Trial:

Request an Annual Quote

Number Crunch Critical Mass for Mass Spec

Premium

The mass-spec market continues to grow by leaps and bounds. A recent UBS Warburg study estimated the 2000 market at $774 million and predicts growth to $1 billion in 2002. The study also analyzed market share and predicted technology growth in the field.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.